MK

Mandeep Kaur

Active Director Director DIN 09302793
DIN 09302793 First appointment Sep 2021 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2021
Shareholding value •••• Premium profile

About Mandeep Kaur

Data last updated:

Mandeep Kaur is a Director at Ellevanta Pharmaceutical Private Limited (since 2021). The company operates in Healthcare. Ellevanta Pharmaceutical Private Limited reported revenue of ₹41.5 Lakh (FY 2025).

DIN 09302793
Primary Designation Director
Industry Healthcare
First Appointment 01 Sep 2021
Oldest Company Age 5 yrs
Largest company Ellevanta Pharmaceutical Private Limited · ₹41.5 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director01 Sep 20212021₹41.5 Lakh (FY 2025)Active

Directorship timeline

Open interactive timeline →
Ellevanta Pharmaceutical Private Limited
Premium access

Shareholding and investment profile for Mandeep Kaur

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mandeep Kaur

Mandeep Kaur currently holds 1 directorship: Ellevanta Pharmaceutical Private Limited (Director, since 01 Sep 2021, revenue ₹41.5 Lakh (FY 2025)).

Mandeep Kaur was first appointed on 01 Sep 2021 as Director at Ellevanta Pharmaceutical Private Limited.

The current boards of Mandeep Kaur's companies include Babita Pandey (Ellevanta Pharmaceutical Private Limited), Nitika Pandey (Ellevanta Pharmaceutical Private Limited), Sudha Pandey (Ellevanta Pharmaceutical Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available